13 11 20

Information and support

  • Get informed
  • Get support
  • Cut my risk
  • Get involved
  • Research
  • Local HER-O

    Acronym: 

    Local HER-O

    ACTRN/NCT /ethics: 

    NCT02898727

    Scientific title: 

    A Study of Local Therapy for the Treatment of Brain Metastases From HER2 Positive Breast Cancer

    Summary of trial and patient characteristics

    Cancer Type Breast
    Trial Type Treatment
    Phase Tumour Stream Breast
    Age Range 18 years and older Cancer Stage Metastatic or Widespread
    Sex Both Anticipated Start Date 2017-11-20
    Molecular Target Anticipated End Date 2020-05-01
    Cancer Type Breast
    Trial Type Treatment
    Phase
    Age Range 18 years and older
    Sex Both
    Molecular Target
    Tumour Stream Breast
    Cancer Stage Metastatic or Widespread
    Anticipated Start Date 2017-11-20
    Anticipated End Date 2020-05-01

    Trial Summary

    This study aims to show that brain metastases from Human Epidermal Growth Factor Receptor Type 2 (HER2) positive breast cancers are able to be controlled by local therapies, Stereotactic Radiosurgery (SRS) and/or Neurosurgery (NS), without the need for Whole Brain Radiotherapy (WBRT).

    Lay Summary

    A Study of Local Therapy for the Treatment of Brain Metastases From HER2 Positive Breast Cancer

    Sponsor / Cooperative group

    TROG Cancer Research

    Participating Hospitals

    Hospital Clinical Trial Coordinator Email Phone Principal Investigator Recruitment Status
    Royal Adelaide Hospital Anne Milton anne.milton@sa.gov.au 08 7074 2342 Professor Hui Tee Recruiting